bladder cancer

Neutrophil-to-Lymphocyte Ratio Not a Prognostic or Predictive Marker for Bladder Cancer

10/31/2016

JCP Editors

The neutrophil-to-lymphocyte ratio (NLR) may not be as reliable as previously believed at predicating cancer progression and which drugs will be the most effective, according to results published in Cancer. Risk...

The...

10/31/2016

Journal of Clinical Pathways

Potential Biomarkers for Bladder Cancer Identified

10/27/2016

JCP Editors

Tumor cells collected during the removal of a cancerous bladder may help clinicians better identify high-risk cancers, determine prognosis, refine their use of biomarkers, and provide more personalized care,...

Tumor...

10/27/2016

Journal of Clinical Pathways

ASCO Endorses EAU Guidelines for Muscle-Invasive, Metastatic Bladder Cancer

03/24/2016

JCP Editors

The American Society of Clinical Oncology (ASCO) has endorsed guidelines established by the European Association of Urology (EAU) for the treatment of muscle-invasive bladder cancer (MIBC) and metastatic bladder...

The...

03/24/2016

Journal of Clinical Pathways